imho most of the screening programs will be government directed and driven. the estimates for costs / deaths of colorectal cancer treatment - for Aus alone comes in at just over $8.5 billion (say 17 yr period) not including loss of life intangibles. I query whether marketing spend will be in issue. for example the cervical cancer screening program simply tells the GP's what process to use (recently changed from Pap smear program to a DNA cytology based program) this has no marketing it was simply government directive because it was superior. I anticipate agreements with govt as national screening program partners as opposed to driven by marketing spend
- Forums
- ASX - By Stock
- RHY
- Ann: CE Mark Granted for ColoSTAT
Ann: CE Mark Granted for ColoSTAT, page-33
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
|
|||||
Last
6.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.66M |
Open | High | Low | Value | Volume |
6.3¢ | 6.3¢ | 6.3¢ | $1.89K | 30K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7568 | 6.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.5¢ | 51999 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7568 | 0.063 |
2 | 125999 | 0.062 |
2 | 83639 | 0.060 |
2 | 19091 | 0.055 |
2 | 38605 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.065 | 51999 | 3 |
0.066 | 107305 | 1 |
0.067 | 195346 | 2 |
0.070 | 1794 | 1 |
0.071 | 10000 | 1 |
Last trade - 10.53am 10/09/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |